Brodalumab: Efficacy, safety, and survival in mid-term (52 weeks) on real clinical practice in Andalucia, Spain

ISSN
00119059
Date Issued
2023
Author(s)
DOI
10.1111/ijd.16527
Subjects

Dermatology